---
title: "LIVZON PHARMA adjusts the maximum cost of acquiring its Vietnamese peer to RMB 1.85 billion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/271115541.md"
description: "LIVZON PHARMA announced that it has entered into a supplementary agreement with the sellers SK Investment, Sunrise, and KBA regarding the acquisition of a total of 64.81% equity in the Vietnamese listed company Imexpharm Corporation, which extends the completion date to June 30, 2026. The adjusted maximum cash consideration for this transaction is 6.891 trillion Vietnamese Dong (approximately 1.846 billion RMB)"
datetime: "2025-12-30T14:13:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271115541.md)
  - [en](https://longbridge.com/en/news/271115541.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271115541.md)
generator: "portal-rs"
---

# LIVZON PHARMA adjusts the maximum cost of acquiring its Vietnamese peer to RMB 1.85 billion

LIVZON PHARMA (01513.HK) announced that it has entered into a supplemental agreement with the sellers SK Investment, Sunrise, and KBA regarding the acquisition of a total of 64.81% equity in the Vietnamese listed company Imexpharm Corporation, extending the completion date to June 30, 2026. The adjusted maximum cash consideration for this transaction is 6.891 trillion Vietnamese Dong (approximately 1.846 billion RMB)

### Related Stocks

- [000513.CN](https://longbridge.com/en/quote/000513.CN.md)
- [01513.HK](https://longbridge.com/en/quote/01513.HK.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Pop Mart grants 137,510 share awards under post-IPO scheme](https://longbridge.com/en/news/296779679.md)
- [AIM Vaccine Seeks Approval for High-Potency Human Diploid Cell Rabies Shot](https://longbridge.com/en/news/296727039.md)
- [Shanghai Bao Pharma says FDA clears IND for KJ015 anti-HER2 bispecific antibody injection](https://longbridge.com/en/news/296768130.md)
- [AIM Vaccine files NMPA registration for high-potency human diploid rabies vaccine](https://longbridge.com/en/news/296714865.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**